Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. | ![]() Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. | ![]() CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | |
Founding Date | Founding Date 2011 | Founding Date 2008 | Founding Date 2008 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Austin, US HQ Montréal, CA | Locations Cambridge, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 13 | Employees 53611% increase | Employees 15815% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 124 m |
Twitter followers | Twitter followers 98 | Twitter followers 2.4 k | Twitter followers 970 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 14 | Number of tweets (last 30 days) 3 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 617754 | Alexa Website Rank 524109 |
Employee Rating | Employee Rating 2.8 | Employee Rating 4.1 | Employee Rating 3.5 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $203.2m (FY, 2020) | Revenue (est.) $100.4m (FY, 2020) |
Net income | Net income N/A | Net income ($327.4m) (FY, 2020) | Net income ($32.9m) (FY, 2020) |
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View companyCytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company